The UCP2 gene encodes a protein called ‘uncoupling protein 2’. In the mitochondria (the main powerhouse of cells), the breakdown of nutrient fuels is coupled to the production of the energy molecule ATP. Members of the uncoupling protein family prevent the production of this molecule and instead cause the energy to be dissipated as heat [R, R].
UCP2 is found in a wide variety of tissues, such as brown an white fat, muscles, pancreatic insulin-producing cells, immune system, heart, and liver. Its expression is increased when blood fatty acid levels are high, such as during fat burning or when eating a high-fat diet. Conversely, obese and diabetic people have lower UCP2 levels [R, R, R, R, R, R].
The biological function of UCP2 remains poorly understood. Although it can block ATP generation to produce heat, just as its sister protein UCP1, research suggests its main role is the regulation of fat and carbohydrate metabolism. UCP2 may also protect the brain and other tissues from oxidative stress [R, R, R, R, R].
The UCP2 gene encodes a mitochondrial protein found in a wide variety of tissues and mainly involved in regulating fat and carbohydrate metabolism.
UCP2 in Fat and Carbohydrate Metabolism
Engineered mice lacking UCP2 were not obese and didn’t gain more weight from a high-fat diet, but burned less fat during fasting and gained more weight when treated with the fat-producing hormone ghrelin. Conversely, mice overproducing UCP2 and UCP3 were leaner [R, R, R, R, R].
Cell-based studies revealed that UCP2 acts as a switch that promotes fat burning on the expense of sugar utilization [R, R].
Additionally, several animal studies showed that UCP2 reduces sugar breakdown by preventing pancreatic cells from secreting insulin in response to high blood glucose. In line with this, the lack of UCP2 expression improved diet-induced diabetes [R, R, R, R, R].
UCP2 promotes fat burning, but can also increase blood sugar by preventing insulin secretion in response to high sugar.
Rs659366
Obesity
The minor ‘T’ variant of the rs659366 polymorphism showed a protective effect from obesity in studies on Austrian and Iranian adults, and Turkish children. Similarly, the major ‘C’ allele was associated with obesity in Danish and Egyptian adults, and Korean, Hungarian, and Spanish children [R, R, R, R, R, R, R, R].
However, no association between this polymorphism and obesity was found in some studies on Danish and Italian adults, and German children. The ‘T’ variant was even associated with increased obesity rates and body fat in Danish, Egyptian, Russian, Spanish, Mexican, Balinese, Indonesian, and Indian adults, and Spanish children [R, R, R, R, R, R, R, R, R, R, R, R, R].
Despite these discrepancies, all meta-analyses agree that the ‘T’ variant is associated with lower obesity rates and BMI in European but not in Asian populations [R, R, R, R].
Blood Fat Levels
The ‘T’ variant has been associated with higher blood triglycerides and cholesterol (both total and ‘bad’ LDL cholesterol) and lower ‘good’ HDL cholesterol levels in French, Mexican, Korean, and Indonesian populations. A Japanese study found it linked to lower LDL particle size, which is a risk factor for heart disease [R, R, R, R, R, R].
Diabetes
The ‘T’ variant has been associated with type 2 diabetes and insulin resistance in Italian (especially women), British, Russian, Indian, and Indonesian populations. Similarly, ‘C’ protected from this condition in an Austrian study [R, R, R, R, R, R, R, R, R].
However, a few studies (on Danish, Chinese, and Italian populations) found the minor variant protective [R, R, R].
Nevertheless, two meta-analyses failed to find an association between this polymorphism and type 2 diabetes in either Asians or Caucasians [R, R].
In Japanese diabetics, ‘T’ was associated with a reduced insulin secretion, and earlier, more frequent need for insulin therapy. Similarly, Chinese carriers of this variant showed worse response to the glucose-lowering drugs repaglinide and rosiglitazone [R, R, R].
This polymorphism is not associated with diabetic kidney disease and the results concerning its link to eye damage are mixed [R, R, R].
However, diabetic carriers of the ‘T’ variant had increased risk of nerve damage and ischemic stroke, as well as worse survival after a heart attack [R, R, R].
How It Works
This polymorphism is located in the region that controls gene expression (the promoter) [R].
Several studies showed that the minor ‘T’ variant increases UCP2 expression in the fatty tissue, pancreas, and liver [R, R, R].
The minor variant of this polymorphism, which increases UCP2 expression, has been associated with reduced obesity rates in Europeans. This variant also seems associated with higher blood fats and worse outcomes of type 2 diabetes.
Rs660339
Obesity
The minor ‘A’ variant of the rs660339 polymorphism has been associated with higher obesity rates, BMI, and body fat in several studies on Japanese, Chinese, Taiwanese, Spanish, and Mexican populations [R, R, R, R, R, R, R, R, R].
However, some studies (on Italian, Danish, and Japanese populations) failed to find this association and a Javanese one even found this variant protective in men [R, R, R, R].
Nevertheless, three different meta-analyses concluded that this variant is associated with obesity, especially in Asians [R, R, R].
Weight Changes
The ‘A’ variant wasn’t associated with weight gain in Dutch populations but enhanced the effects of risk variants at other genes (CNTF in women and IL6 in men) during a follow-up period [R, R].
In diabetics, the variant predicted increased weight gain from antidiabetic medication (rosiglitazone and pioglitazone) [R].
Several studies on Brazilian, Chinese, and Taiwanese populations found that the ‘A’ variant increased weight loss from surgery. However, the effects may not be sustained in the long term: one study associated this variant with eating more calories and carbohydrates after the surgery [R, R, R, R].
Diabetes
The minor ‘A’ variant was associated with increased risk of type 2 diabetes and higher insulin resistance in several studies on American, Chinese (only if overweight), and Taiwanese populations [R, R, R, R].
However, other studies (on American, Chinese, Japanese, and Danish populations) couldn’t find this association. The variant was even protective in Chinese and Asian Indians [R, R, R, R, R, R].
Similarly, a Swedish study couldn’t associate it with susceptibility to metabolic syndrome [R].
Nevertheless, two meta-analyses concluded that the ‘A’ variant is associated with an increased risk of type 2 diabetes in Asian but not in European populations [R, R].
In addition, the ‘A’ variant (both alone and combined with other UCP2 polymorphisms) is associated with increased kidney and eye damage from diabetes [R, R, R].
How It Works
The ‘A’ variant causes an amino acid change that is, however, unlikely to alter the function of the protein. Some scientists believe that this variant simply reflects the effects of other UCP2 polymorphisms inherited together with it [R, R].
Carrying two copies of this variant has been associated with reduced energy expenditure and fat burning in Danish adults and obese Indonesian children, possibly explaining its contribution to obesity [R, R].
The minor variant of this polymorphism has been associated with increased obesity and type 2 diabetes rates, especially in Asians.
Diet
Low-Calorie Mediterranean Diet
The Mediterranean diet is rich in fruits and vegetables, and includes regional foods such as olive oil, nuts, whole grains, fish, and wine. It contains more fiber and polyunsaturated fatty acids (‘healthy fat’) than a standard Western-style diet.
The ‘T’ variant of rs659366 reduced the risk of obesity in Indonesian adolescents eating high-fat diets. In French adolescents, this variant altered energy metabolism to obtain more energy from carbohydrates and less from fats [R, R].
The ‘A’ variant of rs660339 was associated with reduced weight loss from calorie restriction in Korean women. Conversely, Korean women on a very-low-calorie diet and obese Taiwanese taking an appetite-suppressant drug lost more weight if they carried the ‘T’ variant of rs659366 [R, R, R].
A study on Brazilian women found that the UCP2 protein contributed to the effectiveness of a low-calorie diet [R].
Several studies in mice and rats found that UCP2 expression is increased in fatty tissue as a response to high-fat Western diets [R, R, R, R].
The Mediterranean diet is an effective alternative to low-fat and low-carbohydrate diets in weight-loss interventions. Because it improves both blood fat levels and sugar control, this diet also helps prevent heart disease and metabolic disorders such as type 2 diabetes and metabolic syndrome [R, R, R, R].
This diet is most effective when calorie-restricted. Eating low-calorie diets helps reduce fat buildup and food cravings while increasing adiponectin levels and fat burning [R, R].
Coffee
In an Indonesian study, carriers of the ‘T’ variant at rs659366 lost more weight and body fat in response to high coffee intake [R].
Caffeine increased UCP2 expression in the brown fat and muscles of obese mice, as well as in cultured cells [R, R].
Caffeine is a well-known metabolic booster. In 12 clinical trials on 135 people, caffeine (100-600 mg/day) increased energy use and fat burning. Paradoxically, the effects were more pronounced in lean than in overweight people. Caffeine also helped maintain weight loss in 2 long-term studies on 2,500 people [R, R, R, R, R, R, R, R, R, R, R].
Chilli Peppers (Capsaicin)
In a clinical trial on overweight and obese people, a 12-week treatment with non-spicy capsaicin analogs isolated from chilli peppers caused abdominal fat loss. Carrying the ‘T’ variant at rs659366 further enhanced their effects [R].
Both capsaicin and a non-spicy analog (capsiate) increased UCP2 expression in fatty tissues and reduced fat buildup in animal and cell-based studies [R, R, R].
Capsaicin activates receptors (TRPV1) that may speed up the metabolism, increase energy expenditure, and reduce appetite by activating key proteins of energy metabolism [R, R, R, R].
When ingested orally with green tea, capsaicin reduced appetite and food intake in human studies [R, R].
If you like spicy food, you’re in luck: capsaicin is found in chili peppers and is responsible for their spicy flavor. The spicier the pepper, the more capsaicin it contains [R, R].
Fish & Seafood
In mice and rats, dietary fish oil increased UCP2 expression in the muscles and fatty tissues, resulting in an increased fat burning [R, R, R, R, R].
Fish is hypothesized to reduce leptin; higher leptin is associated with obesity. In young, overweight men, the inclusion of fatty fish or fish oil as part of an energy-restricted diet resulted in approximately 1 kg more weight loss after 4 weeks compared to a similar diet without seafood or a supplement [R, R].
Fish oil’s anti-inflammatory effects have the ability to indirectly aid in fat metabolism in people with high inflammation or metabolic syndrome. It can increase the secretion of adiponectin, which is responsible for breaking down fats [R, R].
In a large meta-analysis of 21 clinical trials, fish oil in combination with lifestyle changes significantly reduced waist-to-hip ratio although it failed to improve weight loss [R].
Eating a low-calorie Mediterranean diet, as well as increasing the intake of coffee, chilli peppers, and fish or seafood, help reduce weight. Some UCP2 variants may enhance or reduce the effects of these dietary interventions.
Supplements
Green Tea
Both green tea and its active compound epigallocatechin gallate (EGCG) increased UCP2 expression in both animals fed high-fat diets and fatty cells. In the animal studies, this resulted in reduced fat levels in fatty tissues, blood, and liver [R, R, R, R, R, R].
EGCG caused between 0.2 and 3.5 kg of weight loss in limited human studies. Green tea, meanwhile, is hypothesized to make us burn more calories, even at rest. In most studies, this amounts to a modest 3-4% increase in energy, though some studies have shown an increase as high as 8%. For a 2,000 calorie diet, 3-4% amounts to an additional 60-80 calories per day [R, R, R, R].
In one study of 60 obese individuals, the group taking green tea extract lost 7.3lbs and burned 183 more calories per day (on average) after 3 months [R, R].
Calcium
In mice fed a high-fat and -sugar diet, supplementation with calcium reduced weight gain and increased the expression of the UCP2 and UCP3 genes [R, R].
A clinical trial of 53 people found that calcium (600 mg/day) and vitamin D (125 IU/day) enhanced weight loss when combined with a restricted diet [R].
In another study of 32 obese adults, increased dietary calcium promoted weight loss and fat loss, primarily in the abdomen. Participants who ate a low-calcium diet experienced about 19% of their fat loss from the abdominal region, while those who ate a high-calcium diet experienced about 50% [R].
However, a recent review of 41 studies concluded that calcium supplements don’t increase total weight loss [R].
Conjugated Linoleic Acids
Conjugated linoleic acids (CLA) are poly-unsaturated fatty acids. Studies have shown that CLAs decrease lipid storage by increasing the rate of fat breakdown in fat tissue [R].
In animal studies, including CLA in the diet prevented obesity and increased UCP2 expression in fatty tissues (both white and brown), muscles, and mammary glands [R, R, R, R, R].
A clinical trial on overweight Chinese subjects found that CLA supplementation over a 12-week period reduced body weight, BMI, total fat mass, fat percentage, waist to hip ratio, and subcutaneous fat mass [R].
Berberine
Berberine is an alkaloid with potent metabolic effects. People use berberine as a supplement to support weight control and glucose metabolism.
In animal studies, dietary berberine increased the expression of UCP2 and other genes involved in energy metabolism [R, R, R].
Berberine supplementation reduced BMI and enhanced leptin sensitivity in 37 patients with metabolic syndrome. In another study, it caused an average weight loss of 5 lbs (2.3 kg) and lowered blood lipids [R, R].
According to a 2020 review of human and animal studies, berberine might contribute to weight loss by improving gut microbiota and glucose and fat metabolism [R].
Preliminary research in animals suggests that supplementing with EGCG, calcium, CLA, and berberine may help lose weight, in part by increasing UCP2 levels.